Beta
Company data is growing.
← All companies
/
Top lists
/
Thermo Fisher Scientific
Thermo Fisher Scientific
2016–2025 · 469 US lab companies
2026-08-05
Overview
Earnings
Margins
Cash flow
Balance
Capital
Plot
USD millions
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
18 274
20 918
24 358
25 542
32 218
39 211
44 915
42 857
42 879
44 556
Operating profit (EBIT)
2 449
2 968
3 783
4 594
7 794
10 028
8 393
6 859
7 337
7 746
Net income attributable to shareholders
2 022
2 225
2 938
3 696
6 375
7 725
6 950
5 995
6 335
6 704
EBIT margin
13,4%
14,2%
15,5%
18,0%
24,2%
25,6%
18,7%
16,0%
17,1%
17,4%
Gross margin
55,1%
57,1%
60,3%
83,7%
64,6%
65,3%
68,3%
69,3%
70,8%
69,9%
Operating cash flow
3 158
4 006
4 543
4 973
8 289
9 312
9 154
8 406
8 667
7 818
Free cash flow
2 714
3 498
3 785
4 047
6 815
6 789
6 911
6 927
7 267
6 293
Cash
786
1 335
2 103
2 399
10 325
4 477
8 524
8 077
4 009
9 852
0
20 000
40 000
60 000
0,0%
10,0%
20,0%
30,0%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
18 274
20 918
24 358
25 542
32 218
39 211
44 915
42 857
42 879
44 556
2 449
2 968
3 783
4 594
7 794
10 028
8 393
6 859
7 337
7 746